Author response for "Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrazole) combined with <scp>mTOR</scp> inhibitor (Vistusertib) in endometrial cancer: translational study from the <scp>VICTORIA</scp> trial in collaboration with the <scp>GINECO</scp> group"

crossref(2022)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要